Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain

AIM: To evaluate the long-term safety and efficacy of prolonged-release oxycodone/naloxone (OXN PR) and its impact on quality of life (QoL), in patients with moderate-to-severe cancer pain. METHODS: This was an open-label extension (OLE) of a 4 week, randomized, double-blind (DB) study in which pati...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Support Care Cancer
Главные авторы: Ahmedzai, Sam H., Leppert, Wojciech, Janecki, Marcin, Pakosz, Artur, Lomax, Mark, Duerr, Heike, Hopp, Michael
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2014
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4311064/
https://ncbi.nlm.nih.gov/pubmed/25218610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-014-2435-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы